German China India

Switzerland: Management Structure

Novartis Makes Changes to the Executive Committee

| Editor: Ahlam Rais

Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.
Gallery: 1 image
Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018. (Source: Novartis)

The Group General Counsel of the firm, Felix R. Ehrat is expected to retire on June 1, 2018 following which Shannon Thyme Klinger will lead the team. Robert Weltevreden has also been appointed as Head of Novartis Business Services.

Basel/Switzerland – Novartis has announced today that Felix R Ehrat, Group General Counsel of Novartis, has decided to retire from the company. Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.

Ehrat, who has been Group General Counsel and Member of the Executive Committee of Novartis since 2011, has decided to retire from his position in the context of discussions surrounding the company’s former agreement with Essential Consultants, owned by Michael Cohen.

Shannon Thyme Klinger is currently Chief Ethics, Risk and Compliance Officer. She became Chief Ethics and Compliance Officer and Global Head of Litigation in 2016 and joined the Novartis Executive Committee earlier this year. Klinger joined Novartis in 2011, as General Counsel, North America, Sandoz US. She was then appointed Global Head Legal and General Counsel for Sandoz. Klinger holds a JD with Honors from the University of North Carolina at Chapel Hill.

Before joining Novartis, she was a litigation partner at Mayer Brown and Alston & Bird and was Senior Vice President and General Counsel for Solvay Pharmaceuticals.

Natacha Theytaz, Global Head Internal Audit will lead the Ethics, Risk and Compliance organisation ad interim. Theytaz will join Novartis from Roche, effective June 1, 2018 as already announced internally by Novartis in January 2018.

In addition, the firm also announced today that Robert Weltevreden, previously Head of Business Services for Syngenta will be appointed as Head of Novartis Business Services (NBS). He will report to Vas Narasimhan, CEO of Novartis and become a member of the Executive Committee of Novartis (ECN). He will join Novartis on June 1, 2018 and will be based in Basel.

At Syngenta, Robert Weltevreden led a business services organisation of a similar scope to NBS; including areas such as finance operations, human resources operations, information technology, real estate and facility and fleet management, as well as business process, data and project management. Before that he had roles leading Business Process Management and global Finance Operations for Syngenta. He holds a Masters Degree in International Finance, Economics and Business Administration from the Erasmus University in Rotterdam and an MBA in Financial Management from the Vlerick School for Management, Ghent, Belgium.

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45304298 / Pharma & Food)